| Stacy Roth, APN | |
|
500 W River Dr, Davenport, IA 52801-1014 | |
| (563) 336-3000 | |
| Not Available |
| Full Name | Stacy Roth |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 500 W River Dr, Davenport, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689077018 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0810X | Clinical Nurse Specialist - Psychiatric/mental Health, Child & Family | G106548 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Health Care Inc | 9830008895 | 46 |
| Community Health Care Inc | 9830008895 | 46 |
News Archive
Jackson T. Wright Jr., MD, PhD, and researchers from University Hospitals Case Medical Center presented new results from the Systolic Blood Pressure Intervention Trial (SPRINT) showing that in patients at high risk for cardiovascular events, targeting a systolic blood pressure of less than 120 mm Hg resulted in lower rates of fatal and non-fatal major events or death compared to targeting systolic blood pressure to the usually recommended target of less than 140 mm Hg.
The protocol used to treat the first known survivor of rabies without prior vaccination is published in the June 16, 2005, issue of the New England Journal of Medicine. It is hoped that this approach can be replicated, tested, and provide a guide for treating this fatal condition, especially in parts of the world where the incidence of rabies is rampant.
A new study involving data from more than 20,000 individuals has uncovered several DNA sequences linked to impaired pulmonary function. The research, an analysis that combined the results of several smaller studies, provides insight into the mechanisms involved in reaching full lung capacity.
Secretary of Veterans Affairs Jim Nicholson announced today that President Bush will seek a record $70.8 billion in the fiscal year 2006 budget for the Department of Veterans Affairs (VA), with the overwhelming majority of these resources targeted for health care and disability compensation.
Allegro Ophthalmics, LLC, a company dedicated to establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of vascular eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to begin two Phase II clinical studies of ALG-1001.
› Verified 9 days ago
| Entity Name | Community Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932193224 PECOS PAC ID: 9830008895 Enrollment ID: O20040317000776 |
News Archive
Jackson T. Wright Jr., MD, PhD, and researchers from University Hospitals Case Medical Center presented new results from the Systolic Blood Pressure Intervention Trial (SPRINT) showing that in patients at high risk for cardiovascular events, targeting a systolic blood pressure of less than 120 mm Hg resulted in lower rates of fatal and non-fatal major events or death compared to targeting systolic blood pressure to the usually recommended target of less than 140 mm Hg.
The protocol used to treat the first known survivor of rabies without prior vaccination is published in the June 16, 2005, issue of the New England Journal of Medicine. It is hoped that this approach can be replicated, tested, and provide a guide for treating this fatal condition, especially in parts of the world where the incidence of rabies is rampant.
A new study involving data from more than 20,000 individuals has uncovered several DNA sequences linked to impaired pulmonary function. The research, an analysis that combined the results of several smaller studies, provides insight into the mechanisms involved in reaching full lung capacity.
Secretary of Veterans Affairs Jim Nicholson announced today that President Bush will seek a record $70.8 billion in the fiscal year 2006 budget for the Department of Veterans Affairs (VA), with the overwhelming majority of these resources targeted for health care and disability compensation.
Allegro Ophthalmics, LLC, a company dedicated to establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of vascular eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to begin two Phase II clinical studies of ALG-1001.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stacy Roth, APN 500 W River Dr, Davenport, IA 52801-1014 Ph: (563) 336-3000 | Stacy Roth, APN 500 W River Dr, Davenport, IA 52801-1014 Ph: (563) 336-3000 |
News Archive
Jackson T. Wright Jr., MD, PhD, and researchers from University Hospitals Case Medical Center presented new results from the Systolic Blood Pressure Intervention Trial (SPRINT) showing that in patients at high risk for cardiovascular events, targeting a systolic blood pressure of less than 120 mm Hg resulted in lower rates of fatal and non-fatal major events or death compared to targeting systolic blood pressure to the usually recommended target of less than 140 mm Hg.
The protocol used to treat the first known survivor of rabies without prior vaccination is published in the June 16, 2005, issue of the New England Journal of Medicine. It is hoped that this approach can be replicated, tested, and provide a guide for treating this fatal condition, especially in parts of the world where the incidence of rabies is rampant.
A new study involving data from more than 20,000 individuals has uncovered several DNA sequences linked to impaired pulmonary function. The research, an analysis that combined the results of several smaller studies, provides insight into the mechanisms involved in reaching full lung capacity.
Secretary of Veterans Affairs Jim Nicholson announced today that President Bush will seek a record $70.8 billion in the fiscal year 2006 budget for the Department of Veterans Affairs (VA), with the overwhelming majority of these resources targeted for health care and disability compensation.
Allegro Ophthalmics, LLC, a company dedicated to establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of vascular eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to begin two Phase II clinical studies of ALG-1001.
› Verified 9 days ago
Shelley L. Spector, ARNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1228 E Rusholme St, Suite 302, Davenport, IA 52803 Phone: 563-823-9300 Fax: 563-823-9330 | |
Katherine Anne Fitzpatrick, DNP Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1351 W Central Park Ave, Davenport, IA 52804 Phone: 563-421-1815 | |
Mrs. Lisa Mae Jones, FNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1227 E Rusholme St, Davenport, IA 52803 Phone: 531-421-3122 | |
Concessa Louise Stecker, ARNP Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1441 W Central Park Ave, Davenport, IA 52804 Phone: 563-888-6275 Fax: 563-884-4638 | |
Denise Elaine Antle, ARNP, MSN, CCNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1236 E Rusholme St, Davenport, IA 52803 Phone: 563-421-3994 Fax: 563-421-3999 |